Key facts
- This page summarizes Phillip E. Lee's Form 4 filing for Vaxart, Inc. (VXRT).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 26 Mar 2025, 21:53.
Phillip E. Lee - 24 Mar 2025 Form 4 Insider Report for Vaxart, Inc. (VXRT)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- VXRT
- Reported as of
- 24 Mar 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 26 Mar 2025, 21:53:10 UTC
- Prior SEC filing
- 20 Mar 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Edward Berg, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Phillip E. Lee filed Form 4 for Vaxart, Inc. (VXRT) on 26 Mar 2025.
Change
- Previous filing in this sequence was filed on 20 Mar 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VXRT
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +406,000
- Change %
- +180%
- Price
- $0.000000
- Shares after
- 631,619
- Date
- 24 Mar 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
VXRT
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +610,000
- Change %
- Price
- $0.000000
- Shares after
- 610,000
- Date
- 24 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 610,000
- Exercise price
- $0.5126
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Grant of shares upon vesting of restricted stock units. 25% of the shares underlying the award shall vest on each anniversary of the vesting commencement date of March 24, 2025, so that the restricted stock units would be fully vested on the fourth anniversary of the vesting commencement date.
Footnote F2
The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on March 24, 2026, the first anniversary of the date that vesting commenced, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on March 24, 2029.